Gif sur Yvette, France

Francoise Ochsenbein


Average Co-Inventor Count = 2.8

ph-index = 1


Company Filing History:


Years Active: 2010-2016

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Francoise Ochsenbein

Introduction

Francoise Ochsenbein is a prominent inventor based in Gif sur Yvette, France. She has made significant contributions to the field of biochemistry, particularly in the development of peptides with therapeutic applications. With a total of three patents to her name, her work has the potential to impact cancer treatment and lipid recognition.

Latest Patents

Francoise Ochsenbein's latest patents include innovative peptides that inhibit the interaction between ASF1 and histones. This invention relates to peptides capable of inhibiting the formation of the complex between the Asf1 histone chaperone and histones H3-H4, which can be utilized as a drug for treating cancer. Another notable patent involves marked peptides that have an affinity for phospholipids. This invention features a peptide labeled with fluorine-18 for the specific recognition of lipid vectors, showcasing her expertise in peptide design and application.

Career Highlights

Throughout her career, Francoise has worked with esteemed institutions such as Université Pierre et Marie Curie (Paris VI) and the Commissariat à l'Énergie Atomique. Her research has focused on the intersection of biochemistry and medicine, leading to advancements in therapeutic peptides.

Collaborations

Francoise has collaborated with notable colleagues, including Alain Sanson and Raphael Guerois. These partnerships have contributed to her innovative research and the successful development of her patents.

Conclusion

Francoise Ochsenbein's work exemplifies the impact of innovative research in the field of biochemistry. Her contributions through her patents have the potential to advance cancer treatment and improve our understanding of lipid interactions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…